DUBLIN, March 7, 2024 /PRNewswire/ — The “US Medical Diagnostics Market (Product Type, End-User & Region): Insights & Forecast with Potential Impact of COVID-19 (2024-2028)” report has been added to ResearchAndMarkets.com’s offering.
In-Depth Analysis of U.S. Medical Diagnostics Unveiled, Highlighting COVID-19 Impact and Projections for 2024-2028
Forecasting a robust compound annual growth rate (CAGR) of 4.62% from 2024 to 2028, the U.S. medical diagnostics market is expected to reach a valuation of US$43.89 billion by the year 2028.
The market’s expansion is primarily propelled by several key drivers, including an aging population, the escalating incidence of chronic conditions, increased adoption of Electronic Health Record (EHR) systems, higher healthcare spending, and urban growth. Interestingly, the Southern U.S. region emerges as the fastest growing market within this sector, spurred by growing health awareness and a shift towards point-of-care testing.
Comprehensive U.S. Medical Diagnostics Market Segmentation Unveiled
This market’s analysis is segmented by type, product type, and end-users to provide a detailed landscape of its components. The two main types evaluated are in-vitro and in-vivo diagnostics, with the in-vitro sector analyzed further by product type and application. These product types encompass reagents, instruments, and software & services. The end-user analysis dissects the market into hospitals, diagnostic centers, and Physician Office Labs (POLs), along with other healthcare facilities.
Market Dynamics and Competitive Landscape
Current market dynamics point towards a vibrant industry facing opportunities and challenges alike. The rise of personalized medicine, increased adoption of wearables and healthcare devices, and integration with Artificial Intelligence (AI) mark some of the encouraging trends in the sector. Nevertheless, obstacles such as the shortage of trained lab technicians, high costs of advanced diagnostics equipment, and stringent regulatory requirements pose significant hurdles. This report also offers an in-depth examination of major industry players who are charting the course for market growth.
Target Audience for Key Insights
The contents of this report cater to a varied audience, including but not limited to diagnostic service providers, manufacturers and distributors of In Vitro Diagnostics (IVD) products, hospitals and diagnostic centers, healthcare consultants, and government authorities. It provides valuable perspectives for stakeholders and players contemplating their strategies within the U.S. medical diagnostics space.
Regional Insights into Diagnostics Developments
The report also extends its analysis to regional market performances, specifically focusing on Southern, Mid-Western, Western, and North-Eastern U.S. With detailed assessments, strategic implications, and an understanding of regional nuances, this research becomes a critical tool for decision-makers across the healthcare and diagnostic industries.
In conclusion, the U.S. medical diagnostics market report encompasses a thorough exploration of various facets of the industry, backed by data and forecasts. It serves as a critical repository of analysis for anyone looking to gain a comprehensive understanding of this market’s trajectory over the next few years.
For further insight into this dynamic market, engage with the newly published report available now, providing actionable data and strategic analytics that will shape the future of U.S. medical diagnostics.
Key Topics Covered:
1. Market Overview
1.1 Introduction
1.2 Types of Diagnostics
1.3 General Components of a Diagnostic Procedure
1.4 Anatomy of a Diagnostic Test
1.5 Categories of Diagnostic Tests
1.6 Major Roles of Diagnostic Testing
1.7 Sources of Medical Information for Diagnosis
1.8 Common Types of Diagnostic Tools
2. Impact of COVID-19
2.1 Demand Surge for Medical Diagnostics
2.2 Growth in Government Spending on Healthcare
2.3 Surging Adoption of Diagnostics Based on Reverse-Transcription Polymerase Chain Reaction (RT-PCR)
3. The U.S. Market Analysis
3.1 The U.S. Medical Diagnostics Market by Value
3.2 The U.S. Medical Diagnostics Market Forecast by Value
3.3 The U.S. Medical Diagnostics Market by Type
3.3.1 The U.S. In-Vitro Diagnostics Market by Value
3.3.2 The U.S. In-Vitro Diagnostics Market Forecast by Value
3.3.3 The U.S. In-Vitro Diagnostics Market by Product Type
3.3.4 The U.S. In-Vitro Diagnostics Product Type Market by Value
3.3.5 The U.S. In-Vitro Diagnostics Product Type Market Forecast by Value
3.3.6 The U.S. In-Vitro Diagnostics Market by Application
3.3.7 The U.S. In-Vitro Diagnostics Application Market Forecast by Value
3.3.8 The U.S. In-Vivo Diagnostics Market by Value
3.3.9 The U.S. In-Vivo Diagnostics Market Forecast by Value
3.4 The U.S. Medical Diagnostics Market by Product Type
3.4.1 The U.S. Medical Diagnostics Product Type Market by Value
3.4.2 The U.S. Medical Diagnostics Product Type Market Forecast by Value
3.5 The U.S. Medical Diagnostics Market by End-Users
3.5.1 The U.S. Medical Diagnostics End-User Market by Value
3.5.2 The U.S. Medical Diagnostics End-User Market Forecast by Value
3.6 The U.S. Medical Diagnostics Market by Region
4. Regional Market Analysis
4.1 Southern U.S.
4.1.1 Southern U.S. Medical Diagnostics Market Forecast by Value
4.2 Mid-Western U.S.
4.2.1 Mid-Western U.S. Medical Diagnostics Market Forecast by Value
4.3 Western U.S.
4.3.1 Western U.S. Medical Diagnostics Market Forecast by Value
4.4 North Eastern U.S.
4.4.1 North Eastern U.S. Medical Diagnostics Market Forecast by Value
5. Market Dynamics
5.1 Growth Drivers
5.1.1 Increasing Geriatric Population
5.1.2 Growing Burden of Chronic Diseases
5.1.3 Escalating Penetration of Electronic Health Record (EHR) Systems
5.1.4 Hike in Healthcare Expenditure
5.1.5 Expanding Urbanization
5.2 Key Trends and Developments
5.2.1 Surging Adoption of Healthcare-related Devices Like Wearables
5.2.2 Emergence of Various Pandemic Diseases
5.2.3 Rising Integration with Artificial Intelligence
5.2.4 Growing Awareness on Personalized Medicine
5.3 Challenges
5.3.1 Dearth of Trained Laboratory Technicians
5.3.2 High Cost of High-end Molecular Diagnostics & In-Vitro Diagnostics Devices
5.3.3 Challenging Premarket Approval (PMA) & IVD Labelling Requirements
6. Company Profiles
6.1 Roche Holding AG
6.2 Abbott Laboratories
6.3 Danaher Corporation
6.4 Becton, Dickinson and Company
6.5 Quest Diagnostics Inc.
6.6 BioMerieux SA
For more information about this report visit https://www.researchandmarkets.com/r/mezy4y
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
